Early diagnosis of Amyotrophic Lateral Sclerosis (ALS) and other neurodegenerative disorders
Patent number:
EP22383245
No items found.
An in vitro fluorescent method for early detection of Amyotrophic Lateral Sclerosis (ALS) and other TDP-43 related proteinopathies, such as Fronto Temporal Lobar Degeneration (FTLD), based on detection of pathological aggregates of TDP-43 present in cerebrospinal fluid
Countries:
Spain
Regions:
Community of Madrid
Centers:
CSIC
Other entities:
Sectors:
Health
Subsectors:
TRL Level:
TRL 3 – experimental proof of concept
BRL Level:
PDF Link:
Download hereVideo Link:
Watch it hereSustainable Development Goal:
Applications
Los polipéptidos de TDP-43 oxidados desarrollados son fáciles de producir y exhiben mayor homogeneidad, estabilidad y selectividad que los péptidos de TDP-43 no modificados. Aplicación para la detección de la ELA y otros trastornos neurodegenerativos, como la DLFT, ELA-DLFT, la enfermedad de Alzheimer o la enfermedad de Parkinson. Método útil para el cribado de compuestos útiles para tratar o prevenir las proteinopatías por TDP-43.
Comments
Other related patents
Health
COMBINED FILTER FOR REMOVING TARS AND TOXIC COMPOUNDS FROM TOBACCO SMOKE
Health
METHOD AND SYSTEM FOR PREDICTING GLUCOSE VALUES AND ALERT GENERATION OF HYPOGLYCAEMIA AND HYPERGLYCEMIA (MACHINE-TRANSLATION BY GOOGLE TRANSLATE, NOT LEGALLY BINDING)
Health

32.jpg)


56.jpg)